Seqirus joins international vaccine venture to develop long-lasting, universal flu vaccine

Seqirus (owned by CSL) has joined an international, non-profit venture dedicated to decoding the immune system to develop a universal flu vaccine that affords long-lasting protection against seasonal and pandemic influenza across demographics and geography. The Human Vaccines Project aims to decode the human immune system to accelerate development of vaccines and immunotherapies against major…

Read More

Influencing the digital landscape

VIVA! Communications’ Principal, Kirsten Bruce, had the pleasure of presenting to Melbourne’s leading pharma marketers about how to influence the digital landscape at the Melbourne Pharma Marketing (MPM) breakfast seminar, hosted by Princeton Digital, at The Cullen Prahran, Melbourne on Monday, June 20, 2018. Entitled Marketing reinvented: New rules and new tools in this digital…

Read More

World Digestive Health Day 2018

Today is World Digestive Health Day (WDHD) 2018, supported by the World Gastroenterology Organisation (WGO). Digestive disorders can range from obesity to cancers to diarrhoeal disorders, the latter of which is ranked in the top 10 causes of mortality globally. WDHD aims to increase general public awareness of prevention, prevalence, diagnosis, management and treatment of…

Read More

Urgent community plea to reverse declining vaccination rates against fatal lung infection this Pneumonia Awareness Week

Lung Foundation Australia is teaming with researchers, doctors and patients Australia-wide today, during Pneumonia Awareness Week (13-20 May), to call for proactive community action to address the declining vaccination rates against pneumococcal pneumonia – an infection responsible for more than 15,000 GP visits, 8,000 hospitalisations, and 2,000 deaths among those aged over 65 each year. Their…

Read More